• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿朴斯皂苷元通过激活维生素 D 受体抑制结肠炎相关癌症中的上皮-间充质转化。

Asperuloside inhibited epithelial-mesenchymal transition in colitis associated cancer via activation of vitamin D receptor.

机构信息

School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.

School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.

出版信息

Phytomedicine. 2022 Jul;101:154070. doi: 10.1016/j.phymed.2022.154070. Epub 2022 Mar 22.

DOI:10.1016/j.phymed.2022.154070
PMID:35523114
Abstract

BACKGROUND

Asperuloside is a natural compound extracted from various herbs with several bioactivities. Its effects on anti-inflammation and anti-tumor indicated that asperuloside might prevent colorectal cancer developing from inflammatory bowel diseases (IBD). But there were few reports about the efficacy and mechanism of asperuloside on improving colorectal cancer. It has been reported that vitamin D receptor (VDR) could regulate the expression of SMAD3. In previous study, asperuloside could significantly improve the expression of VDR and reduced Smad3 mRNA in IEC-6 cell.

PURPOSE

The present study was aimed to investigate the potential mechanism of asperuloside on inhibiting epithelial-mesenchymal transition (EMT) in colitis associated cancer.

STUDY DESIGN

First, in LPS-injured IEC-6 cell, asperuloside inhibited phosphorylated p65 (p-p65) level, improved VDR expression and reduced Smad3 mRNA. Second, we wonder the relationship between VDR signaling and nucleus factor-kappaB (NF-κB) signaling during asperuloside on reducing Smad3 mRNA. And then, the effect of asperuloside on inhibiting EMT development through VDR/Smad3 was investigated. Finally, we testified the effect of asperuloside on protecting against colitis associated cancer (CAC) by inhibiting EMT development through VDR/Smad3.

METHODS

Pyrrolidinedithiocarbamate ammonium (PDTC) was used for established NF-κB-inhibited IEC-6 cell. This cell was applied for investigating the relationship between NF-κB and VDR of asperuloside on inhibiting Smad3. VDR-inhibited cell was established by small interfering RNA (siRNA) of VDR and was employed to investigate the role of VDR for asperuloside on decreasing Smad3. Transforming growth factor β1 (TGFβ1) was used for inducing EMT/fibrosis in IEC-6 cell. TGFβ1-stimulated cell was used for testifying the effect of asperuloside on inhibiting EMT development. AOM/DSS-induced CAC was established to investigate the effect of asperuloside on suppressing cancer development.

RESULTS

Asperuloside inhibited the level of p-p65 which was up-regulated by LPS. Asperuloside could up-regulate VDR signaling and reduce Smad3 mRNA in NF-κB-knockdown IEC-6 cells. Asperuloside failed to reduce Smad3 mRNA due to VDR knockdown, which implied that asperuloside might down-regulate Smad3 mRNA dependently on activation of VDR signaling and independently on inhibiting NF-κB signaling. Asperuloside exhibited significant prevention of EMT development in TGFβ1-induced IEC-6 cell (EMT cell) and mice CAC. Asperuloside reduced the transform of epithelial phenotype into motile mesenchymal phenotype in EMT cell along with decreasing levels of EMT markers by inhibiting Smad3 mRNA via activation of VDR. In mice with CAC, expression of VDR in colon was improved by asperuloside. Symptoms of colitis, tumor number and tumor size were significantly inhibited by asperuloside. Suppressed EMT development was determined by reduced α-SMA expression and decreased mRNAs of several EMT markers.

CONCLUSION

Asperuloside might prevent CAC through inhibiting EMT development via regulation of VDR/Smad3 pathway.

摘要

背景

山柰酚是一种从多种草药中提取的天然化合物,具有多种生物活性。其抗炎和抗肿瘤作用表明,山柰酚可能预防从炎症性肠病(IBD)发展而来的结直肠癌。但是,关于山柰酚改善结直肠癌的疗效和机制的报道很少。据报道,维生素 D 受体(VDR)可以调节 SMAD3 的表达。在之前的研究中,山柰酚可以显著改善 IEC-6 细胞中 VDR 的表达,并降低 Smad3 mRNA 的水平。

目的

本研究旨在探讨山柰酚抑制结肠炎相关癌症上皮-间充质转化(EMT)的潜在机制。

研究设计

首先,在 LPS 损伤的 IEC-6 细胞中,山柰酚抑制磷酸化 p65(p-p65)水平,提高 VDR 表达并降低 Smad3 mRNA。其次,我们想研究山柰酚降低 Smad3 mRNA 过程中 VDR 信号与核因子-κB(NF-κB)信号之间的关系。然后,通过 VDR/Smad3 研究山柰酚对抑制 EMT 发展的作用。最后,通过 VDR/Smad3 抑制 EMT 发展,验证山柰酚对预防结肠炎相关癌症(CAC)的作用。

方法

用吡咯烷二硫代氨基甲酸盐铵(PDTC)建立 NF-κB 抑制的 IEC-6 细胞。该细胞用于研究山柰酚抑制 Smad3 过程中 NF-κB 和 VDR 之间的关系。用小干扰 RNA(siRNA)抑制 VDR 建立 VDR 抑制细胞,用于研究 VDR 对山柰酚降低 Smad3 的作用。转化生长因子β1(TGFβ1)用于诱导 IEC-6 细胞 EMT/纤维化。用 TGFβ1 刺激细胞,验证山柰酚抑制 EMT 发展的作用。用 AOM/DSS 诱导 CAC,研究山柰酚抑制癌症发展的作用。

结果

山柰酚抑制了 LPS 上调的 p-p65 水平。山柰酚可上调 NF-κB 敲低的 IEC-6 细胞中的 VDR 信号,并降低 Smad3 mRNA。由于 VDR 敲低,山柰酚未能降低 Smad3 mRNA,这表明山柰酚可能依赖于 VDR 信号的激活,独立于抑制 NF-κB 信号来下调 Smad3 mRNA。山柰酚在 TGFβ1 诱导的 IEC-6 细胞(EMT 细胞)和小鼠 CAC 中表现出显著的 EMT 发展抑制作用。山柰酚通过抑制 Smad3 mRNA,通过激活 VDR,显著降低 EMT 标志物的水平,从而抑制 EMT 细胞的上皮表型向运动性间充质表型的转化。在 CAC 小鼠中,山柰酚改善了结肠中的 VDR 表达。山柰酚显著抑制了结肠炎、肿瘤数量和肿瘤大小的症状。通过减少α-SMA 表达和降低几种 EMT 标志物的 mRNA,证实 EMT 发展受到抑制。

结论

山柰酚可能通过调节 VDR/Smad3 通路抑制 EMT 发展,从而预防 CAC。

相似文献

1
Asperuloside inhibited epithelial-mesenchymal transition in colitis associated cancer via activation of vitamin D receptor.阿朴斯皂苷元通过激活维生素 D 受体抑制结肠炎相关癌症中的上皮-间充质转化。
Phytomedicine. 2022 Jul;101:154070. doi: 10.1016/j.phymed.2022.154070. Epub 2022 Mar 22.
2
Asperuloside suppressing oxidative stress and inflammation in DSS-induced chronic colitis and RAW 264.7 macrophages via Nrf2/HO-1 and NF-κB pathways.阿朴斯皂苷通过 Nrf2/HO-1 和 NF-κB 通路抑制 DSS 诱导的慢性结肠炎和 RAW264.7 巨噬细胞中的氧化应激和炎症。
Chem Biol Interact. 2021 Aug 1;344:109512. doi: 10.1016/j.cbi.2021.109512. Epub 2021 May 8.
3
HLJ2 Effectively Ameliorates Colitis-Associated Cancer via Inhibition of NF-κB and Epithelial-Mesenchymal Transition.HLJ2 通过抑制 NF-κB 和上皮-间充质转化有效缓解结肠炎相关癌症。
Drug Des Devel Ther. 2020 Oct 15;14:4291-4302. doi: 10.2147/DDDT.S262806. eCollection 2020.
4
[Chrysin inhibited epithelial-mesenchymal transition of type Ⅱ alveolar epithelial cell by regulating NF-κB/Twist 1 signaling pathway].白杨素通过调控NF-κB/Twist 1信号通路抑制Ⅱ型肺泡上皮细胞上皮-间质转化
Zhongguo Zhong Yao Za Zhi. 2021 Jan;46(1):146-154. doi: 10.19540/j.cnki.cjcmm.20200810.402.
5
Loss of vitamin D receptor in chronic kidney disease: a potential mechanism linking inflammation to epithelial-to-mesenchymal transition.慢性肾脏病中维生素 D 受体的缺失:炎症向上皮间质转化的潜在机制。
Am J Physiol Renal Physiol. 2012 Oct;303(7):F1107-15. doi: 10.1152/ajprenal.00151.2012. Epub 2012 Jul 11.
6
Tumor necrosis factor-α coordinates with transforming growth factor-β1 to induce epithelial-mesenchymal transition and migration via the NF-κB/NOX4 pathway in bronchial epithelial cells.肿瘤坏死因子-α与转化生长因子-β1协同作用,通过 NF-κB/NOX4 通路诱导支气管上皮细胞上皮-间充质转化和迁移。
Mol Biol Rep. 2022 Oct;49(10):9325-9333. doi: 10.1007/s11033-022-07777-4. Epub 2022 Aug 1.
7
Vitamin D receptor inhibits EMT via regulation of the epithelial mitochondrial function in intestinal fibrosis.维生素 D 受体通过调节肠道纤维化中的上皮线粒体功能抑制 EMT。
J Biol Chem. 2021 Jan-Jun;296:100531. doi: 10.1016/j.jbc.2021.100531. Epub 2021 Mar 11.
8
Vitamin D prevents the intestinal fibrosis via induction of vitamin D receptor and inhibition of transforming growth factor-beta1/Smad3 pathway.维生素D通过诱导维生素D受体和抑制转化生长因子-β1/Smad3信号通路来预防肠道纤维化。
Dig Dis Sci. 2015 Apr;60(4):868-75. doi: 10.1007/s10620-014-3398-6. Epub 2014 Oct 19.
9
Vitamin D/VDR signaling inhibits colitis by suppressing HIF-1α activation in colonic epithelial cells.维生素 D/VDR 信号通过抑制结肠上皮细胞中 HIF-1α 的激活来抑制结肠炎。
Am J Physiol Gastrointest Liver Physiol. 2021 May 1;320(5):G837-G846. doi: 10.1152/ajpgi.00061.2021. Epub 2021 Mar 24.
10
Liuwei Dihuang Decoction Drug-containing Serum Attenuates Transforming Growth Factor-β1-induced Epithelial-mesenchymal Transition in HK-2 Cells by Inhibiting NF-κB/Snail Signaling Pathway.六味地黄汤含药血清通过抑制 NF-κB/Snail 信号通路减轻转化生长因子-β1 诱导的 HK-2 细胞上皮间质转化。
Curr Pharm Biotechnol. 2023;24(12):1589-1602. doi: 10.2174/1389201024666230228100718.

引用本文的文献

1
Inflammation-fibrosis interplay in inflammatory bowel disease: mechanisms, progression, and therapeutic strategies.炎症性肠病中炎症与纤维化的相互作用:机制、进展及治疗策略
Front Pharmacol. 2025 Feb 28;16:1530797. doi: 10.3389/fphar.2025.1530797. eCollection 2025.
2
Monotropein inhibits epithelial-mesenchymal transition in chronic colitis via the mTOR/P70S6K pathway.九头狮子草素通过mTOR/P70S6K信号通路抑制慢性结肠炎中的上皮-间质转化。
Front Pharmacol. 2025 Feb 18;16:1536091. doi: 10.3389/fphar.2025.1536091. eCollection 2025.
3
Shared and specific competing endogenous RNAs network mining in four digestive system tumors.
四种消化系统肿瘤中共享和特异性竞争性内源RNA网络挖掘
Comput Struct Biotechnol J. 2024 Nov 5;23:4271-4287. doi: 10.1016/j.csbj.2024.11.005. eCollection 2024 Dec.
4
Phytochemical Compounds as Promising Therapeutics for Intestinal Fibrosis in Inflammatory Bowel Disease: A Critical Review.植物化学物质作为炎症性肠病中肠纤维化的有前途的治疗方法:批判性评价。
Nutrients. 2024 Oct 25;16(21):3633. doi: 10.3390/nu16213633.
5
Ginsenoside Rb1 Alleviates DSS-Induced Ulcerative Colitis by Protecting the Intestinal Barrier Through the Signal Network of VDR, PPARγ and NF-κB.人参皂苷 Rb1 通过维生素 D 受体、过氧化物酶体增殖物激活受体 γ 和核因子-κB 信号网络保护肠道屏障缓解 DSS 诱导的溃疡性结肠炎。
Drug Des Devel Ther. 2024 Oct 29;18:4825-4838. doi: 10.2147/DDDT.S481769. eCollection 2024.
6
Confronting the global obesity epidemic: investigating the role and underlying mechanisms of vitamin D in metabolic syndrome management.应对全球肥胖流行:探究维生素D在代谢综合征管理中的作用及潜在机制。
Front Nutr. 2024 Aug 9;11:1416344. doi: 10.3389/fnut.2024.1416344. eCollection 2024.
7
Asperuloside inhibits the activation of pancreatic cancer-associated fibroblasts via activating transcription factor 6.车叶草苷通过激活转录因子6抑制胰腺癌相关成纤维细胞的活化。
Discov Oncol. 2024 Jun 19;15(1):234. doi: 10.1007/s12672-024-01095-w.
8
Modulation of the vitamin D receptor by traditional Chinese medicines and bioactive compounds: potential therapeutic applications in VDR-dependent diseases.中药及生物活性化合物对维生素D受体的调节作用:在维生素D受体依赖性疾病中的潜在治疗应用
Front Pharmacol. 2024 Jan 22;15:1298181. doi: 10.3389/fphar.2024.1298181. eCollection 2024.
9
Asperuloside regulates the proliferation, apoptosis, and differentiation of chronic myeloid leukemia cell line K562 through the RAS/MEK/ERK pathway.车叶草苷通过RAS/MEK/ERK信号通路调控慢性髓系白血病细胞系K562的增殖、凋亡及分化。
Heliyon. 2023 Dec 16;10(1):e23580. doi: 10.1016/j.heliyon.2023.e23580. eCollection 2024 Jan 15.
10
Targeting the key players of phenotypic plasticity in cancer cells by phytochemicals.通过植物化学物质靶向癌细胞表型可塑性的关键参与者。
Cancer Metastasis Rev. 2024 Mar;43(1):261-292. doi: 10.1007/s10555-023-10161-8. Epub 2024 Jan 3.